Concepedia
Statistics
Publications
19
Citations
700
H-Index
17
Active since
1961
Affiliations
University of Manchester(Current)
AstraZeneca (United Kingdom)
FibroGen (United States)
Institut Pasteur
East Cheshire NHS Trust
Philip N. Edwards is an author at University of Manchester specializing in enzyme inhibition, pharmacology, and chemistry.
Publications per year
1961–2008
The preclinical pharmacology of “Arimidex” (Anastrozole; ZD1033) — a potent, selective aromatase inhibitor
Michael Dukes, Philip N. Edwards, M. S. Large et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 90 citations
Medicine, Medicinal Chemistry, Pharmacology +14
Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors
G. C. CRAWLEY, Robert I. Dowell, Philip N. Edwards et al. · Journal of Medicinal Chemistry · 1992 · 86 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +15
Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening
João Neres, Mark L. Brewer, Laura Ratier et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 68 citations · Full text
Pharmacy, Chemical Biology, Medicinal Chemistry +13
Aminoimidazolylmethyluracil Analogues as Potent Inhibitors of Thymidine Phosphorylase and Their Bioreductive Nitroimidazolyl Prodrugs
Philip Reigan, Philip N. Edwards, Abdul M Gbaj et al. · Journal of Medicinal Chemistry · 2004 · 47 citations · Full text
Medicine, Oncology, Pharmacology +14
Potential Tumor-Selective Nitroimidazolylmethyluracil Prodrug Derivatives: Inhibitors of the Angiogenic Enzyme Thymidine Phosphorylase
Christian Cole, Philip Reigan, Abdul M Gbaj et al. · Journal of Medicinal Chemistry · 2002 · 45 citations · Full text
Pharmacy, Oncology, Pharmacology +14
1–5 of 19